Raising the Bar for Myelofibrosis Therapy Development

(MedPage Today) -- Rational combination therapies, new-generation drugs, and new therapeutic targets will push treatment for myelofibrosis beyond the current focus on the Janus kinase (JAK) inhibition, a specialist said during the Society of Hematologic...